Business Standard

Tatva Chintan makes solid debut; lists at 95% premium over issue price

The stock price of the specialty chemicals more-than-doubled or zoomed 133 per cent at Rs 2,534.20 against its issue price of Rs 1,083 within a few seconds of its listing on the NSE

Tatva Chintan makes stellar debut; stock lists 95% premium over issue price
Premium

SI Reporter Mumbai
Tatva Chintan Pharma Chem made a stellar stock market debut, with its shares getting listed at a whopping 95 per cent premium over its issue price of Rs 1,083 per share on the National Stock Exchange (at Rs 2,111.85) and BSE (at Rs 2,111.80).

The stock of the specialty chemicals more-than-doubled or zoomed 133 per cent at Rs 2,534.20 within a few seconds of its listing on the NSE. On the BSE, the stock hit an intra-day high of Rs 2,486.30 post its listing. At 10:02 am, it was trading at Rs 2,289.65 on the NSE. A combined 2.7

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in